You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Bendamustine for the first-line treatment of chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA216
  • Published:  23 February 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Bendamustine for first treatment of chronic lymphocytic leukaemia (PDF 61 KB)

    Published:
    23 February 2011
  • Gwybodaeth i'r cyhoedd (Word 431 KB)

    Published:
    18 May 2011
Back to top